ArticleFrontiers in immunology2021

Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma.

Wenjing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.